New Needle-Free fix for hemorrhoid bleeding put to the test
NCT ID NCT05697562
First seen Jan 11, 2026 · Last updated Jun 16, 2026 · Updated 22 times
Summary
This study tests a new, less invasive procedure called superior rectal artery embolization (SRAE) for controlling bleeding from hemorrhoids. It involves blocking small arteries to stop bleeding without cutting or damaging the anal area. The study will enroll 80 adults with grade I-III hemorrhoids and compare SRAE to standard treatments like rubber band ligation or Doppler-guided HAL. The goal is to see if SRAE works just as well for symptom control.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMORRHOIDS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UZ Brussel
RECRUITINGJette, 1090, Belgium
Contact Phone: •••-•••-••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.